Cargando…

Sigma-1 receptor: a potential new target for Parkinson's disease?

Detalles Bibliográficos
Autor principal:	Francardo, Veronica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281425/ https://www.ncbi.nlm.nih.gov/pubmed/25558236 http://dx.doi.org/10.4103/1673-5374.145351

Ejemplares similares

Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson’s Disease
por: Francardo, Veronica, et al.
Publicado: (2019)

Sigma-1 receptor and neuroprotection: current outlook and potential therapeutic effects
por: Li Volti, Giovanni, et al.
Publicado: (2016)

Sigma-2 receptor as a potential therapeutic target for treating central nervous system disorders
por: Terada, Kazuki, et al.
Publicado: (2019)

Sigma-1 receptor: culprit and rescuer in motor neuron diseases
por: Liévens, Jean-Charles, et al.
Publicado: (2020)

SLP-2: a potential new target for improving mitochondrial function in Parkinson's disease
por: Zanon, Alessandra, et al.
Publicado: (2017)

Gut microbiota: a potential therapeutic target for Parkinson’s disease
por: Baizabal-Carvallo, José Fidel
Publicado: (2020)

Targeting Sigma-1 Receptor: A Promising Strategy in the Treatment of Parkinson’s Disease
por: Siddiqui, Talha, et al.
Publicado: (2023)

Genetics provides new individualized therapeutic targets for Parkinson’s disease
por: Garcia, Eric Joshua, et al.
Publicado: (2020)

Substance P and its tachykinin NK1 receptor: a novel neuroprotective target for Parkinson's disease
por: Thornton, Emma, et al.
Publicado: (2015)

The Sigma Receptors in Alzheimer’s Disease: New Potential Targets for Diagnosis and Therapy
por: Wang, Tao, et al.
Publicado: (2023)

Potential role of biofeedback therapy for Parkinson’s disease
por: Kotani, Naoya, et al.
Publicado: (2021)

Targeting chaperone-mediated autophagy for Parkinson’s disease therapy
por: Wang, Yi-Ting, et al.
Publicado: (2023)

Limited therapeutic potential of astrocyte elevated gene-1 transduction in an animal model of Parkinson's disease
por: Leem, Eunju, et al.
Publicado: (2020)

The integrative role of G protein-coupled receptor heterocomplexes in Parkinson’s disease
por: Borroto-Escuela, Dasiel O., et al.
Publicado: (2022)

New perspectives in iron chelation therapy for the treatment of Parkinson’s disease
por: Nuñez, Marco T., et al.
Publicado: (2019)

Gene therapy in Parkinson's disease: targeting the endplasmic reticulum proteostasis network
por: Castillo, Valentina, et al.
Publicado: (2015)

Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2017)

Clues from a missense mutation of the adenosine A(1) receptor gene associated with early-onset Parkinson’s disease
por: Ferré, Sergi, et al.
Publicado: (2023)

Bacterial melanin in rat models of Parkinson's disease: a potential neuroprotective strategy
por: Petrosyan, Tigran
Publicado: (2015)

Sigma-1 Receptor: A Potential Therapeutic Target for Traumatic Brain Injury
por: Shi, Mingming, et al.
Publicado: (2021)

The innate immune system in Parkinson's disease: a novel target promoting endogenous neuroregeneration
por: Schlachetzki, Johannes CM, et al.
Publicado: (2015)

Alpha-Klotho in Parkinson’s disease: a perspective on experimental evidence and potential clinical implications
por: Grillo, Piergiorgio, et al.
Publicado: (2022)

The dual role of necrostatin-1 in Parkinson’s disease models
por: Alegre-Cortés, Eva, et al.
Publicado: (2021)

Biochemical consequences of glucocerebrosidase 1 mutations in Parkinson’s disease
por: Yoon, Jeong Hyun, et al.
Publicado: (2023)

The Intriguing Sigma-1 and Sigma-2 Receptors and Their Potential Therapeutic Roles 2.0
por: Abate, Carmen, et al.
Publicado: (2023)

The Wnt/β-catenin signaling: a multifunctional target for neuroprotective and regenerative strategies in Parkinson’s disease
por: Serafino, Annalucia, et al.
Publicado: (2022)

Emerging non-invasive therapeutic approaches targeting hypocholinergic neural systems in Parkinson’s disease
por: Bohnen, Nicolaas I., et al.
Publicado: (2022)

Emerging small-molecule therapeutic approaches for Alzheimer's disease and Parkinson's disease based on targeting microRNAs
por: Abdelrahman, Somaya A., et al.
Publicado: (2021)

The new wave of p75 neurotrophin receptor targeted therapies
por: Crooks, Amanda M., et al.
Publicado: (2021)

PINK1: From Parkinson’s disease to mitophagy and back again
por: O’Callaghan, Benjamin, et al.
Publicado: (2023)

Cell Therapies for Parkinson's Disease
por: Irion, Stefan
Publicado: (2019)

Mitochondria in the context of Parkinson's disease
por: Villacé, Patricia, et al.
Publicado: (2017)

Falling upward with Parkinson’s disease
por: Buetow, Stephen A., et al.
Publicado: (2017)

Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease
por: Brunetti, Leonardo, et al.
Publicado: (2019)

Pharmacology and Therapeutic Potential of Sigma(1) Receptor Ligands
por: Cobos, E.J, et al.
Publicado: (2008)

Is serine racemase (SRR) a second hit target for LRRK2-G2019S induced Parkinson’s disease?
por: Nickels, Sarah Louise, et al.
Publicado: (2020)

COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside
por: Sulzer, David, et al.
Publicado: (2020)

Inhibition of microglial activation and induction of neurotrophic factors by flavonoids: a potential therapeutic strategy against Parkinson's disease
por: Kim, Sang Ryong
Publicado: (2015)

Targeting the transferrin receptor to develop erythropoietin for Alzheimer's disease
por: Sumbria, Rachita K.
Publicado: (2020)

Adenosine A(2A)-dopamine D(2) receptor heteromers operate striatal function: impact on Parkinson's disease pharmacotherapeutics
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gnugd3stfpug3lqkuraa913nd7